A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam.

PHASE2CompletedINTERVENTIONAL
Enrollment

446

Participants

Timeline

Start Date

September 18, 2019

Primary Completion Date

February 28, 2020

Study Completion Date

March 3, 2020

Conditions
Acne Vulgaris
Interventions
COMBINATION_PRODUCT

FCD105

Experimental combination

DRUG

3% Minocycline Foam

Active Comparator

DRUG

0.3% Adapalene Foam

Active Comparator

OTHER

Vehicle Foam

Placebo

Trial Locations (35)

10022

Foamix Institution #115, New York

11790

Foamix Institution #108, Stony Brook

27262

Foamix Institution #104, High Point

29464

Foamix Institution #119, Mt. Pleasant

32055

Foamix Institution #127, Lake City

32771

Foamix Institution #118, Sanford

33016

Foamix Institution #107, Hialeah

33126

Foamix Institution #101, Miami

33162

Foamix Institution #135, Miami Beach

33351

Foamix Institution #120, Sunrise

33607

Foamix Institution #128, Tampa

40241

Foamix Institution #123, Louisville

46168

Foamix Institution #116, Plainfield

47150

Foamix Institution #130, New Albany

48038

Foamix Institution #114, Clinton Township

55432

Foamix Institution #111, Fridley

70115

Foamix Institution #124, New Orleans

70809

Foamix Institution #126, Baton Rouge

72022

Foamix Institution #134, Bryant

72758

Foamix Institution #121, Rogers

76011

Foamix Institution #110, Arlington

77845

Foamix Institution #117, College Station

78213

Foamix Institution #105, San Antonio

78660

Foamix Institution #112, Pflugerville

84041

Foamix Institution #131, Layton

89148

Foamix Institution #102, Las Vegas

90266

Foamix Institution #109, Manhattan Beach

91436

Foamix Institution #106, Encino

92123

Foamix Institution #132, San Diego

92647

Foamix Institution #122, Huntington Beach

94538

Foamix Institution #103, Fremont

97030

Foamix Institution #133, Gresham

99202

Foamix Institution #113, Spokane

02472

Foamix Institution #136, Watertown

02919

Foamix Institution #125, Johnston

All Listed Sponsors
lead

Vyne Therapeutics Inc.

INDUSTRY

NCT04104685 - A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam. | Biotech Hunter | Biotech Hunter